skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Implementation of exome sequencing in fetal diagnostics—Data and experiences from a tertiary center in Denmark

Acta obstetricia et gynecologica Scandinavica, 2020-06, Vol.99 (6), p.783-790 [Peer Reviewed Journal]

2020 Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). Published by John Wiley & Sons Ltd ;2020 Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). Published by John Wiley & Sons Ltd. ;Nordic Federation of Societies of Obstetrics and Gynecology ;ISSN: 0001-6349 ;EISSN: 1600-0412 ;DOI: 10.1111/aogs.13871 ;PMID: 32304219

Full text available

Citations Cited by
  • Title:
    Implementation of exome sequencing in fetal diagnostics—Data and experiences from a tertiary center in Denmark
  • Author: Becher, Naja ; Andreasen, Lotte ; Sandager, Puk ; Lou, Stina ; Petersen, Olav Bjørn ; Christensen, Rikke ; Vogel, Ida
  • Subjects: Congenital diseases ; exome ; fetal diagnostics ; fetal malformations ; Fetuses ; Genetic testing ; Medical diagnosis ; next‐generation sequencing ; Pregnancy ; prenatal diagnosis ; prenatal testing
  • Is Part Of: Acta obstetricia et gynecologica Scandinavica, 2020-06, Vol.99 (6), p.783-790
  • Description: Introduction Applying whole‐exome sequencing (WES) for the diagnosis of diseases in children has shown significant diagnostic strength compared with chromosomal microarray. WES may also have the potential of adding clinically relevant prenatal information in cases where a fetus is found to have structural anomalies. We present results from the first fetal exomes performed in a tertiary center in Denmark. Material and methods Couples/expectant parents were included in Central Denmark Region from July 2016 to March 2019. Inclusion was not systematic, but where one or more fetal malformations or severe fetal hydrops were detected, and a specific diagnosis had not been obtained by chromosomal microarray. WES was performed in ongoing pregnancies (N = 11), after intrauterine demise (N = 5), or after termination of pregnancy based on ultrasound findings (N = 19). In most cases, a trio format was applied comprising fetal and parental DNA. Results WES was performed in 35 highly selected fetal cases. Pathogenic variants, or variants likely to explain the phenotype, were detected in 9/35 (26%). Variants of uncertain significance were detected in 7/35 (20%) and there was one secondary finding (3%). Out of the 11 ongoing pregnancies, four reached a genetic diagnosis (36%). Detection rate was highest in cases of multisystem anomalies (7/13, 54%). WES was completed in all three trimesters and both autosomal dominant, autosomal recessive and X‐linked inheritance were revealed. Conclusions We present data from 35 cases of exome sequencing applied in a setting of fetal malformations. Importantly, though, we wish to share our personal experiences with implementing WES into a prenatal setting. As a medical society, we must continue to share what we do not understand, what went wrong, what is difficult, and what we do not agree upon. A common understanding and language are warranted. We also advocate that more research is needed concerning the clinical value, as well as costs and patient perspectives, of using WES in pregnancy. We believe that WES will lead to improved prenatal and perinatal care.
  • Publisher: United States: Wiley Subscription Services, Inc
  • Language: English
  • Identifier: ISSN: 0001-6349
    EISSN: 1600-0412
    DOI: 10.1111/aogs.13871
    PMID: 32304219
  • Source: Journals@Ovid Open Access Journal Collection Rolling

Searching Remote Databases, Please Wait